> ## Content Index
> Fetch the complete content index at: https://www.healthdatacon.io/llms.txt
> Use this file to discover other available public pages before exploring further.

# Picking Quality Measures for Future MU Stages
- URL: https://www.healthdatacon.io/articles/picking-quality-measures-for-future-mu-stages/
- Published: 2010-12-07T22:05:19.000Z
- Updated: 2010-12-07T22:05:19.000Z
- Description: The quality measures workgroup of the HIT Policy Committee is seeking public input through Dec. 23 as it develops recommendations for clinical quality measures in Stages 2 and 3 of the electronic health records meaningful use criteria.
- Author: HDM Staff
- Tags: Informatics

The quality measures workgroup of the HIT Policy Committee is seeking public input through Dec. 23 as it develops recommendations for clinical quality measures in Stages 2 and 3 of the electronic health records meaningful use criteria.  
  
In a new entry on the Federal Advisory Committee Blog site, the workgroup requests general comments and specific examples of measures for each measure concept that fit the following criteria:  
  
\* HIT-sensitive--Capable of being built into electronic health record (EHR) systems with implementation of relevant health IT functions (e.g., clinical decision support) that result in improved outcomes and/or clinical performance.  
  
\* Parsimonious--Applies across multiple types of providers, care settings and conditions.  
  
\* Demonstrates preventable burden--Supports potential improvements in population health and reduces burden of illness.  
  
\* Assesses health risk status and outcomes--Supports assessment of patient health risks that can be used for risk adjusting other measures, and assessing changes in outcomes, including general cross-cutting measures of risk status and functional status and condition-specific measures.  
  
\* Longitudinal--Enables assessment of longitudinal, condition-specific, patient-focused episodes of care.  
  
"Your comments will inform the work of the HIT Policy Committee in supporting the development of HIT-sensitive clinical quality measures; these comments are important to shaping public policy on the future of e-measure development," writes workgroup chair David Lansky. [Click here](http://healthit.hhs.gov/blog/faca/index.php/2010/12/06/quality-measures-workgroup-seeks-comment-on-clinical-quality-measures-concepts-for-stage-2-and-stage-3-meaningful-use-by-december-23-2010/?ref=healthdatacon.io#more-387) for more information.  
  
\--Joseph Goedert